EiPLA
EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).
≈ 10 min read
EiPLA. encyclopegia.org, snapshot enwiki-001374834742. /a/eipla
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[2][3][1] It is an isomer of ETH-LAD.[1]
Use and effects
edit edit sourceEiPLA has been identified in blotter containing doses of 86 to 97 μg base equivalent per tab.[1] Blotter containing 200 μg per tab has also been described.[1] Anecdotal reports suggest that EiPLA produces psychedelic effects but is less potent than LSD.[1]
Interactions
edit edit sourcePharmacology
edit edit sourcePharmacodynamics
edit edit sourceIn drug discrimination tests in rodents, EiPLA was found to have approximately half the potency of LSD.[2][3][1]
Chemistry
edit edit sourceAnalogues
edit edit sourceAnalogues of EiPLA include MiPLA, LAMPA (MPLA), EPLA, EcPLA, and ETFELA, among others.[1][4]
History
edit edit sourceEiPLA was first described in the scientific literature by David E. Nichols and colleagues by at least 1994.[2] It appears to have emerged as a novel designer drug by 2019.[1]
See also
edit edit sourceReferences
edit edit source- ^ a b c d e f g h i Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Stratford A, et al. (February 2024). "Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD)". Drug Testing and Analysis. 16 (2): 187–198. doi:10.1002/dta.3530. PMID 37321559. Wikipedia revision 1374834742, retrieved 2026-11-18
- ^ a b c Huang X, Marona-Lewicka D, Pfaff RC, Nichols DE (March 1994). "Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives". Pharmacology, Biochemistry, and Behavior. 47 (3): 667–673. doi:10.1016/0091-3057(94)90172-4. PMID 8208787. Wikipedia revision 1374834742, retrieved 2026-11-18
- ^ a b Nichols DE (October 2018). "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)". ACS Chemical Neuroscience. 9 (10): 2331–2343. doi:10.1021/acschemneuro.8b00043. PMID 29461039. Wikipedia revision 1374834742, retrieved 2026-11-18
- ^ Wachełko O, Nowak K, Tusiewicz K, Zawadzki M, Szpot P (January 2025). "A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies". Analyst. 150 (2): 290–308. doi:10.1039/d4an01361a. PMID 39636448. Wikipedia revision 1374834742, retrieved 2026-11-18
External links
edit edit source Psychedelics- No substitutions: Ergine (LSA, LA-111)
- Isoergine (iso-LSA, iso-LA)
- Amide-substituted lysergamides: DAL
- DAM (DAM-57)
- DiPLA
- DPL
- EcPLA
- EiPLA
- EPLA (LEP; LEP-57)
- Ergometrine (ergonovine, ergobasine)
- ETFELA
- iPLA
- LA-3Cl-SB (Cl-LSB)
- LAE (LAE-32)
- LAM
- LAMPA
- LAP
- LME (LME-54)
- LMP (LMP-55)
- LPD (LPD-824)
- LSB
- LSD (LSD-25, METH-LAD; lysergide)
- LSD-Pip
- LSDP (DPL)
- LSH (LAH)
- LSM (LSM-775)
- 2-LSP
- LSP (3-LSP)
- LSZ (LA-SS-Az)
- Lysergic acid pyrrolinide (LPN)
- Methylergometrine (methylergonovine, methylergobasine)
- MiPLA
- TRALA-12 (didehydro-LSD; DDH-LSD)
- 6-Alkyllysergamides: BU-LAD
- CE-LAD (CHLORETH-LAD)
- CPM-LAD
- CYP-LAD (TRALA-22)
- ETH-LAD
- FLUORETH-LAD (FE-LAD)
- FP-LAD
- IP-LAD
- NBOMe-LAD
- PARGY-LAD
- PRO-LAD
- 1-Alkyllysergamides (prodrugs): Methysergide (1-methylmethylergonovine; UML-491)
- MLA-74 (1-methyl-LAE)
- MLD-41 (1-methyl-LSD)
- MPD-75 (1-methyl-LPD)
- OML-632 (1-hydroxymethyl-LSD)
- 1-Acyllysergamides (prodrugs): 1-Formyl-LSD
- 1B-LSD
- 1BP-LSD
- 1Bz-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 1D-AL-LAD
- 1D-LSD
- 1DD-LSD
- 1F-LSD
- 1Fe-LSD
- 1H-LSD
- 1P-AL-LAD
- 1P-ETH-LAD
- 1P-LSD
- 1P-MiPLA
- 1S-LSD
- 1SB-LSD (1BS-LSD; 1-TMSBz-LSD)
- 1T-AL-LAD
- 1T-LSD
- 1V-LSD
- ALA-10 (1-acetyl-LAE; 1A-LAE)
- ALD-52 (1-acetyl-LSD; 1A-LSD)
- Bioisosteres: JRT (isotryptamine-LSD)
- 9-Oxaergolines (e.g., RU-29717)
- γ-Carbolines (e.g., tiflucarbine)
- Arylpiperazines (e.g., 2C-B-PP, 2-NP, mCPP, MK-212, ORG-12962, pCPP, pFPP, quipazine, TFMPP, VCU-1012)
- Dihydrobenzoxazines (e.g., efavirenz)
- Ergolines (e.g., pergolide)
- Phenoxyethylamines (e.g., CT-4719, ORG-37684)
- Pyridopyrroloquinoxalines (e.g., IHCH-7113)
- Quinazolinylethylamines (e.g., RH-34)
- Tryptamines: Acacia spp. (e.g., Acacia acuminata, Acacia confusa)
- Ayahuasca and vinho de Jurema (e.g., Psychotria viridis (chacruna), Dipolopterys cabrerana (chaliponga, chacruna), Mimosa tenuiflora (Mimosa hostilis; jurema))
- Brosimum (e.g., Brosimum acutifolium (takini))
- Hallucinogenic snuffs (e.g., Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene), Anadenanthera colubrina (vilca, cebil))
- Incilius alvarius (Bufo alvarius; Colorado River toad, Sonoran Desert toad; bufo)
- Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g., Psilocybe cubensis, Psilocybe mexicana (teonanacatl))
- Phenethylamines: Echinopsis cacti (e.g., San Pedro, Peruvian torch)
- Pachycereus cacti (e.g., Pachycereus pecten-aboriginum, Pachycereus pringlei)
- Peyote (Lophophora williamsii; peyotl)
- Lysergamides: Achnatherum robustum (sleepy grass)
- Epichloë spp.
- Ergot (Claviceps) (e.g., Claviceps purpurea, Claviceps paspali)
- Morning glory (Convolvulaceae) seeds (e.g., Ipomoea tricolor (tlitliltzin, badoh negro; Ipomoea violacea), Ipomoea corymbosa (coaxihuitl, ololiúqui; Rivea Corymbosa, Turbina Corymbosa), Argyreia nervosa (Hawaiian baby woodrose; HBWR))
- Periglandula spp. (e.g., Periglandula ipomoeae, Periglandula clandestina)
(incl. lysergines)
- 13-Fluorolysergol
- Acetergamine
- BAM-2101
- BAM-2201
- Brazergoline
- Bromerguride (2-bromolisuride)
- Cianergoline
- Delergotrile
- Descarboxylysergic acid
- Dihydrolysergic acid
- Disulergine
- Dosergoside
- Ergolene
- Ergoline
- Etisulergine
- FCE-22716
- LEK-8829
- Lergotrile
- Lisuride
- LY-158A (6-ethylpergolide)
- LY-53857
- LY-86057
- LY-108742
- LY-116467 (LY-062; 6-methylpergolide)
- LY-193525
- LY-197541
- LY-215840
- LY-225297
- LY-254239
- Lysergene
- Lysergic acid
- Lysergic acid methyl ester
- Lysergine
- Lysergol
- Mesulergine
- Metergoline
- MDL
- Nicergoline
- Paspalic acid (δ8-lysergic acid)
- Pergolide
- Pibocin A
- Pibocin B
- Proterguride
- Romergoline
- SDZ 208-911
- SDZ 208-912
- Sergolexole
- Terguride
- Tiomergine
- VUFB-6683 (Deprenon)
(6,8-dimethylergolines)
- 6,8-Dimethylergoline (clavine)
- 9-Deacetoxyfumigaclavine C
- Agroclavine
- Costaclavin
- Elymoclavine
- Epoxyagroclavine
- Festuclavine
- Fumigaclavine A
- Fumigaclavine B
- Fumigaclavine C
- Penniclavine
- Setoclavine
- Partial ergolines and related: Chanoclavine
- Chanoclavine II
- Cycloclavine
- Paliclavine
(lysergic acid amides)
- Non-hallucinogenic lysergamides: 1P-BOL-148
- 2-Bromo-LSD (bromolysergide; BOL-148)
- 2-Iodo-LSD
- 2-Oxo-LSD (2-keto-LSD)
- 2-Oxo-3-hydroxy-LSD
- 9,10-Dihydro-LSD
- Amesergide
- AWD 52-39
- Cabergoline
- D13H (possibly XC101-D13H)
- Ergometrinine
- Iso-LSD (d-iso-LSD)
- l-Iso-LSD
- l-LSD
- LEK-1814
- LEK-8804 (N-(2-propynyl)lysergamide)
- LEK-8822
- LEK-8827
- LEK-8841
- Lumi-LSD
- LY-215,840
- Lysergic acid 2-heptylamide
- Lysergic acid 2-hexylamide
- Lysergic acid cyclobutylamide (LAcB)
- Lysergic acid cyclopentylamide (cepentil; LCyP)
- Lysergic acid dibutylamide (LBB-66)
- MBL-61 (MOB-61; 1-methyl-2-bromo-LSD)
- MIL (1-methyl-2-iodo-LSD)
- NIBR2130
- PHENETHY-LAD
- SPT-348
- Psychedelic lysergamides: 1B-LSD
- 1BP-LSD
- 1Bz-LSD
- 1cP-AL-LAD
- 1cP-LSD
- 1cP-MiPLA
- 1D-AL-LAD
- 1D-LSD
- 1DD-LSD
- 1F-LSD
- 1Fe-LSD
- 1H-LSD
- 1P-AL-LAD
- 1P-ETH-LAD
- 1P-LSD
- 1P-MiPLA
- 1S-LSD
- 1SB-LSD (1BS-LSD; 1-TMSBz-LSD)
- 1T-AL-LAD
- 1T-LSD
- 1V-LSD
- 2,3-Dihydro-LSD
- AL-LAD
- ALA-10 (1-acetyl-LAE)
- ALD-52 (1-acetyl-LSD)
- BU-LAD
- CPM-LAD
- CYP-LAD
- Diallyllysergamide (DAL)
- Dimethyllysergamide (DAM-57)
- Diisopropyllysergamide (DiPLA)
- Dipropyllysergamide (DPL)
- Ergine (lysergic acid amide; LSA; LA-111; lysergamide)
- Ergometrine (ergonovine, ergobasine)
- ETH-LAD
- Ethylcyclopropyllysergamide (EcPLA)
- Ethylisopropyllysergamide (EiPLA)
- Ethylpropyllysergamide (EPLA; LEP-57)
- Ethyltrifluoroethyllysergamide (ETFELA)
- IP-LAD
- Isoergine (isolysergic acid amide; iso-LSA; iso-LA; isolysergamide)
- Isopropyllysergamide (iPLA; LAiP)
- Lysergic acid diethylamide (LSD; d-LSD; lysergide)
- Lysergic acid ethylamide (LAE-32, LAE)
- Lysergic acid hydroxyethylamide (LSH, LAH)
- Lysergic acid methylamide (LAM)
- Lysergic acid methylethylamide (LME-54)
- Lysergic acid morpholide (LSM-775)
- Lysergic acid propylamide (LAP)
- Lysergic acid pyrrolidide (LPD-824)
- Lysergic acid 2-butylamide (LSB)
- Lysergic acid 2,4-dimethylazetidide (LA-SS-Az, LSZ, LA-Azetidine)
- Lysergic acid 2-pentylamide (2-LSP)
- Lysergic acid 3-pentylamide (LSP, 3-LSP)
- Methylergometrine (methylergonovine, methylergobasine; Methergine)
- Methylisopropyllysergamide (MiPLA)
- Methylpropyllysergamide (LAMPA, LMP-55)
- Methysergide (1-methylmethylergonovine; UML-491)
- MLA-74 (1-methyl-LAE)
- MLD-41 (1-methyl-LSD)
- MPD-75 (1-methyllysergic acid pyrrolidide)
- NBOMe-LAD
- OML-632 (1-hydroxymethyl-LSD)
- PARGY-LAD
- PRO-LAD
- TRALA-12 (didehydro-LSD; DDH-LSD)
- Unsorted lysergamides: 1-Dimethylaminomethyl-LSD
- 2-Br-14-Me-LSD
- 12-Hydroxy-LSD
- 12-Methoxy-LSD
- 13-Fluoro-LSD
- 13-Hydroxy-LSD
- 14-Hydroxy-LSD
- 14-Methoxy-LSD
- 14-Methyl-LSD
- CE-LAD
- Dihydroergometrine (dihydroergonovine, dihydroergobasine)
- Ergovalide
- FLUORETH-LAD
- FP-LAD
- Lysergic acid azepane (LA-Azepane)
- Lysergic acid-(2,3-dimethylaziridinyl)amide (LA-Aziridine)
- LEK-8842 (TRALA-01)
- LA-Cispip (LA-cis-2,6-DiMePip)
- LA-Cispyr (LA-cis-2,5-DiMePyr)
- Lysergic acid α-methylbenzylamide
- Lysergic acid amylamide
- Lysergic acid butylamide
- Lysergic acid ethyl-2-butylamide
- Lysergic acid ethyl-2-hydroxyethylamide (LEO)
- Lysergic acid ethyl-2-methoxyethylamide (LA-MeO)
- Lysergic acid methyl-2-butylamide
- Lysergic acid piperidide (LA-Pip, LSD-Pip)
- Lysergic acid pyrrolinide (LPN)
- Lysergic acid tert-butylamide (LAtB)
- Lysergyl-alanine
- Lysergyl-L-valyl methyl ester
- MAL-LAD
- Propisergide (1-methylergonovine)
(peptide ergolines)
- Bromocriptine
- Dihydroergocornine
- Dihydroergocristine
- Dihydroergocryptine
- Dihydroergosine
- Dihydroergotamine
- Epicriptine
- Ergocornine
- Ergocristine
- Ergocryptine
- Ergoloid (dihydroergotoxine; Hydergine)
- Ergonine
- Ergosine
- Ergostine
- Ergotamine
- Ergotoxine
- Ergovaline
- Fludihydroergotamine
- Mergocriptine
- Metergotamine
- 2-Aminotetralins (e.g., 8-OH-DPAT, rotigotine, U-92016A, UH-232)
- 3,4-DMPEA-NDEPA
- 5-MeO-N-DEAOP-NET
- 5-MeO-N-DEAOP-NMT
- 10,11-Secoergoline (α,N-Pip-T)
- 10,11-Seco-LSD (UCD0121)
- 25B-NAcPip
- 25D-NM-NDEAOP (25D-NM-NDEPA)
- 2C-B-3PIP
- Bay R 1531 (LY-197206)
- CT-5252
- Diaza-2C-DFLY
- Debenzergoline
- DMAI (UCD0076; 4-DMAEI)
- DOB-NDEPA
- DOI-NDEPA
- DOM-NDEPA
- DOTFM-NDEPA
- DPAI (4-DPAEI; 2-desoxo-2-ene-ropinirole)
- FAEFHI
- FHATHBIN
- 7-Hydroxyropinirole (SK&F-89124)
- LPH-5 ((S)-2C-TFM-3PIP)
- LY-178210
- LY-293284
- LY-301317
- M-NDEPA
- 6-MeO-RU-28306
- N-DEAOP-NMPEA (PEA-NM-NDEPA)
- N-DEAOP-NMT
- NDTDI (8,10-seco-LSD)
- Phenethylamines
- Ropinirole
- RU-27251
- RU-27849
- RU-28251
- RU-28306 (UCD0094)
- THPC (UCD0162)
- TMA-2-NDEPA
- Tryptamines
- UCD0068 (des-B-LSD)
- UCD0120 (dides-B,C-LSD)
- UCD0120-2C-D
- UCD0120-mescaline
- UCD0120-NAP
- UCD0120-PMA
- UCD0179 (3,5-seco-LSD)
- UCD0829
- UCD0830 (N,N-DiMe-2-AT)
- WXVL_BT0793LQ2118
- Related: Mefloquine
- Nikethamide
- Tochergamine
- Fungi: Clavicipitaceae
Text derived from https://en.wikipedia.org/w/index.php?oldid=1374834742 under CC BY-SA 4.0; modifications have been made.